Lv4
620 积分 2022-02-25 加入
Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer
3天前
已完结
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn’s-like inflammatory bowel disease
1个月前
已完结
The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus
1个月前
已完结
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
1个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
2个月前
已完结
Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy
2个月前
已完结
Anti-inflammatory role of the IgA Fc receptor (CD89): From autoimmunity to therapeutic perspectives
2个月前
已完结
The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis
2个月前
已完结
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study
2个月前
已完结
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis
2个月前
已完结
皖公网安备34019202002308
